- Home
- CDNA vs BHRB Comparison
CDNA vs BHRB Comparison
Compare CDNA & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- BHRB
- Stock Information
- Founded
- CDNA 1998
- BHRB 1852
- Country
- CDNA United States
- BHRB United States
- Employees
- CDNA N/A
- BHRB N/A
- Industry
- CDNA Medical Specialities
- BHRB Major Banks
- Sector
- CDNA Health Care
- BHRB Finance
- Exchange
- CDNA Nasdaq
- BHRB Nasdaq
- Market Cap
- CDNA 712.2M
- BHRB 852.6M
- IPO Year
- CDNA 2014
- BHRB N/A
- Fundamental
- Price
- CDNA $13.53
- BHRB $61.57
- Analyst Decision
- CDNA Buy
- BHRB Strong Buy
- Analyst Count
- CDNA 8
- BHRB 3
- Target Price
- CDNA $26.86
- BHRB $71.67
- AVG Volume (30 Days)
- CDNA 1.5M
- BHRB 46.4K
- Earning Date
- CDNA 11-03-2025
- BHRB 10-24-2025
- Dividend Yield
- CDNA N/A
- BHRB 3.57%
- EPS Growth
- CDNA N/A
- BHRB N/A
- EPS
- CDNA 1.00
- BHRB 6.89
- Revenue
- CDNA $340,826,000.00
- BHRB $330,001,000.00
- Revenue This Year
- CDNA $13.02
- BHRB $51.44
- Revenue Next Year
- CDNA $12.85
- BHRB $3.58
- P/E Ratio
- CDNA $13.56
- BHRB $8.94
- Revenue Growth
- CDNA 14.72
- BHRB 164.69
- 52 Week Low
- CDNA $10.96
- BHRB $47.57
- 52 Week High
- CDNA $32.97
- BHRB $75.32
- Technical
- Relative Strength Index (RSI)
- CDNA 52.36
- BHRB 48.06
- Support Level
- CDNA $13.12
- BHRB $61.93
- Resistance Level
- CDNA $13.80
- BHRB $62.92
- Average True Range (ATR)
- CDNA 0.67
- BHRB 1.19
- MACD
- CDNA 0.16
- BHRB -0.17
- Stochastic Oscillator
- CDNA 63.39
- BHRB 0.00
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About BHRB Burke & Herbert Financial Services Corp.
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.